Ontozry (cenobamate)
Focal-onset seizures in adults with epilepsy
ApprovedActive
Key Facts
Indication
Focal-onset seizures in adults with epilepsy
Phase
Approved
Status
Active
Company
About Angelini Pharma
Angelini Pharma is a century-old, private Italian pharmaceutical company with a significant international commercial footprint across Europe and the United States. Its strategy is built on a diversified portfolio spanning prescription drugs in Brain Health, Specialty Care, and over-the-counter Consumer Healthcare products. The company demonstrates a clear commitment to its core therapeutic areas through ongoing commercial initiatives, medical education platforms like Headway, and a pipeline that includes recently launched CNS products such as Ontozry.
View full company profile